RNA5SP206

Across TCGA pan-cancer cohorts, RNA5SP206 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated RNA5SP206 data layer compared with 17 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNA5SP206 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP206 expression acts as an unfavorable survival marker.

BRCA, BLCA, and CESC are the cancer types where RNA5SP206 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.656	0.924	.001	32	view →
BLCA	OS	Median	All	0.153	0.618	.006	18	view →
CESC	DFS	Median	All	0.092	0.543	.018	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNA5SP206–BRCA (OS)

Open the BRCA breakdown →